FIELD: biotechnology.
SUBSTANCE: invention relates to use of acute phase proteins for therapy of mastitis caused by S. Aureus in cattle. Isoform 3 of serum amyloid A (SAA-3) is used by intramammary infusion in the dead period.
EFFECT: invention enables effective control of the infection and improving mammary gland involution during the period of onset.
12 cl, 8 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MAMMAL MILK CELLS, COMPOSITIONS CONTAINING THEM, AND USING THEM FOR TREATING MASTITIS | 2008 |
|
RU2446814C2 |
| LYPOTEICHOIC ACID FROM LACTIC ACID BACTERIA AND USES THEREOF IN MODULATION OF IMMUNE REACTIONS MEDIATED BY GRAM-NEGATIVE BACTERIA AND POTENTIAL PATHOGENIC GRAM-POSITIVE BACTERIA | 2002 |
|
RU2320356C2 |
| USE OF A SYMBIOTIC CONSORTIUM OF PROBIOTIC LACTOBACILLI STRAINS ISOLATED FROM HUMAN MILK, WHICH HAS A BACTERICIDAL EFFECT ON MASTITIS-INDUCING PATHOGENS, FOR THE MANUFACTURE OF DRUGS FOR THE COMPLEX PREVENTION AND TREATMENT OF LACTATIONAL MASTITIS | 2022 |
|
RU2801119C1 |
| MODULATION OF IMMUNE FUNCTION BY MEANS OF BOVINE LACTOFERRIN | 2013 |
|
RU2644018C2 |
| COMPOSITION BASED UPON THE PROTEINS OF ENAMEL MATRIX FOR MODULATING IMMUNE RESPONSE | 2002 |
|
RU2295972C2 |
| COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS | 2018 |
|
RU2760008C2 |
| HUMANIZED M-CSF MICE | 2020 |
|
RU2819731C2 |
| APPLICATION OF SERUM AMYLOID A GENE FOR DIAGNOSIS AND THERAPY OF GLAUCOMA AND IDENTIFICATION OF ANTIGLAUCOMATOUS AGENT | 2007 |
|
RU2461378C2 |
| HUMANISED M-CSF MICE | 2012 |
|
RU2730643C2 |
| METHODS OF TREATING MICROBIAL INFECTIONS, INCLUDING MASTITIS | 2014 |
|
RU2662300C2 |
